| Relief from episodic weakness with pyridostigmine in paramyotonia congenita: a family study. | |
| | |
MedLine Citation:
|
PMID: 19768756 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Pyridostigmine relieved episodic weakness in a family with paramyotonia congenita resulting from the R1448C mutation in the sodium channel gene. The transmission was autosomal dominant and the patients had paradoxical myotonia and exercise-induced weakness. On electrophysiological studies there were myotonic potentials, and there was progressive reduction of compound muscle action potential (CMAP) amplitudes after short exercise associated with clinical weakness. Pyridostigmine in doses of 60 mg three times daily abolished the drop in the postexercise CMAP amplitude and reduced the amplitude decrement to slow rate repetitive stimulation, but there continued to be a drop in amplitude on exposure to cold. The decline of the CMAP amplitude on exposure to cold was controlled by treatment with phenytoin. The clinical and electrophysiological features are discussed in relation to therapy with pyridostigmine and phenytoin. |
| | |
Authors:
|
Satish V Khadilkar; R K Singh; K A Mansukhani; J A Urtizberea; D Sternberg |
Related Documents
:
|
3094606 - Cold air test: a simplified standard method for airway reactivity. 9543646 - An acute dose of nicotine enhances cue-induced cocaine craving. 18565566 - Uptake and depuration of anatoxin-a by the mussel mytilus galloprovincialis (lamarck, 1... 11514306 - Short-term exercise training can improve myocardial tolerance to i/r without elevation ... 432716 - The influence of backrest inclination and lumbar support on lumbar lordosis. 2783076 - Effects of exercise-induced weight loss on low density lipoprotein subfractions in heal... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Muscle & nerve Volume: 41 ISSN: 1097-4598 ISO Abbreviation: Muscle Nerve Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2009-12-21 Completed Date: 2010-01-15 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7803146 Medline TA: Muscle Nerve Country: United States |
Other Details:
|
Languages: eng Pagination: 133-7 Citation Subset: IM |
Affiliation:
|
Department of Neurology, Grant Medical College and Sir JJ Group of Hospitals, Mumbai, and Honorary Neurologist, 110, New Wing, First Floor, Bombay Hospital, 12, New Marine Lines, Mumbai, India. khadilkar@vsnl.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Cholinesterase Inhibitors / therapeutic use Electromyography Female Follow-Up Studies Humans Muscle Weakness / drug therapy*, etiology, physiopathology Myotonic Disorders / complications*, drug therapy, physiopathology Pedigree Pyridostigmine Bromide / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Cholinesterase Inhibitors; 101-26-8/Pyridostigmine Bromide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Consensus statement: The use of intravenous immunoglobulin in the treatment of neuromuscular conditi...
Next Document: Campylobacter jejuni abscess, encephalomyelitis, and acute polyradiculoneuropathy.